Cargando…
Chitosan oligosaccharide suppresses osteosarcoma malignancy by inhibiting CEMIP via the PI3K/AKT/mTOR pathway
Osteosarcoma is a malignant bone tumor that is prone to metastasize early and primarily affects children and adolescents. Cell migration-inducing protein (CEMIP) plays a crucial role in the progression and malignancy of various tumor diseases, including osteosarcoma. Chitosan oligosaccharide (COS),...
Autores principales: | Sim, IlJin, Choe, WonGyom, Ri, JinJu, Su, Hang, Moqbel, Safwat Adel Abdo, Yan, WeiQi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480286/ https://www.ncbi.nlm.nih.gov/pubmed/37668818 http://dx.doi.org/10.1007/s12032-023-02165-9 |
Ejemplares similares
-
Nesfatin-1 Promotes the Osteogenic Differentiation of Tendon-Derived Stem Cells and the Pathogenesis of Heterotopic Ossification in Rat Tendons via the mTOR Pathway
por: Xu, Kai, et al.
Publicado: (2020) -
CEMIP Promotes Osteosarcoma Progression and Metastasis Through Activating Notch Signaling Pathway
por: Cheng, Jun, et al.
Publicado: (2022) -
mTOR: An attractive therapeutic target for osteosarcoma?
por: Ding, Liu, et al.
Publicado: (2016) -
Research on the biological mechanism and potential application of CEMIP
por: Liu, Yang, et al.
Publicado: (2023) -
Nuclear receptor modulators inhibit osteosarcoma cell proliferation and tumour growth by regulating the mTOR signaling pathway
por: Yuan, Baoshi, et al.
Publicado: (2023)